Orange Book product · Generic (ANDA)
CEFTAZIDIME
CEFTAZIDIME
At a glance
Feb 03, 1992
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 03, 1992
34 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFTAZIDIME
Strength
6GM/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 062640
Product number
004
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of CEFTAZIDIME
- 2011CEFTAZIDIME IN DEXTROSE CONTAINERBrand (NDA)
NDA 050823 · B BRAUN
- 1990CEPTAZBrand (NDA)
NDA 050646 · GLAXOSMITHKLINE
- 1985FORTAZBrand (NDA)
NDA 050578 · PAI HOLDINGS PHARM
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065481 · AUROBINDO PHARMA LTD
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065482 · AUROBINDO PHARMA LTD
- 2008CEFTAZIDIMEGeneric (ANDA)
ANDA 065196 · WOCKHARDT
- 1995PENTACEFGeneric (ANDA)
ANDA 063322 · GLAXOSMITHKLINE
- 1993TAZICEFGeneric (ANDA)
ANDA 064032 · HOSPIRA
- 1992PENTACEFGeneric (ANDA)
ANDA 064006 · GLAXOSMITHKLINE
- 1992PENTACEFGeneric (ANDA)
ANDA 064008 · GLAXOSMITHKLINE
- 1986TAZIDIME IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062739 · LILLY
- 1986TAZICEFGeneric (ANDA)
ANDA 062662 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
